Published in PLoS One on October 21, 2015
Heparan sulfate hexasaccharide selectively inhibits cancer stem cells self-renewal by activating p38 MAP kinase. Oncotarget (2016) 0.78
Estimating glycosaminoglycan-protein interaction affinity: water dominates the specific antithrombin-heparin interaction. Glycobiology (2016) 0.75
2-O, 3-O Desulfated Heparin Blocks High Mobility Group Box 1 Release by Inhibition of p300 Acetyltransferase Activity. Am J Respir Cell Mol Biol (2017) 0.75
The Good the Bad and the Ugly of Glycosaminoglycans in Tissue Engineering Applications. Pharmaceuticals (Basel) (2017) 0.75
All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B (1998) 54.00
CHARMM: the biomolecular simulation program. J Comput Chem (2009) 27.71
Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis (1989) 5.88
Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol Cell (2000) 5.72
Interactions between heparan sulfate and proteins: the concept of specificity. J Cell Biol (2006) 3.49
The anticoagulant activation of antithrombin by heparin. Proc Natl Acad Sci U S A (1997) 3.09
Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. Bioessays (1998) 3.04
Structural insights into biological roles of protein-glycosaminoglycan interactions. Chem Biol (2005) 2.67
Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin. Nat Struct Mol Biol (2004) 2.26
On the calculation of electrostatic interactions in proteins. J Mol Biol (1985) 2.21
Contribution of monosaccharide residues in heparin binding to antithrombin III. Biochemistry (1985) 1.89
Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain. Biochemistry (1994) 1.76
Demystifying heparan sulfate-protein interactions. Annu Rev Biochem (2014) 1.76
Quantitative characterization of the thrombin-heparin interaction. Discrimination between specific and nonspecific binding models. J Biol Chem (1991) 1.72
Crystal structure of thrombin bound to heparin. J Biol Chem (2004) 1.61
Structural analysis of the sulfotransferase (3-o-sulfotransferase isoform 3) involved in the biosynthesis of an entry receptor for herpes simplex virus 1. J Biol Chem (2004) 1.41
Biomolecular electrostatics and solvation: a computational perspective. Q Rev Biophys (2012) 1.39
A systems biology approach for the investigation of the heparin/heparan sulfate interactome. J Biol Chem (2011) 1.39
Crystal structure and mutational analysis of heparan sulfate 3-O-sulfotransferase isoform 1. J Biol Chem (2004) 1.38
Mechanism of heparin activation of antithrombin. Role of individual residues of the pentasaccharide activating sequence in the recognition of native and activated states of antithrombin. J Biol Chem (1998) 1.34
Predominant contribution of surface approximation to the mechanism of heparin acceleration of the antithrombin-thrombin reaction. Elucidation from salt concentration effects. J Biol Chem (1991) 1.29
Finding a needle in a haystack: development of a combinatorial virtual screening approach for identifying high specificity heparin/heparan sulfate sequence(s). J Med Chem (2006) 1.28
Localization and characterization of a heparin binding domain peptide of human von Willebrand factor. J Biol Chem (1992) 1.17
New antithrombin-based anticoagulants. Med Res Rev (2004) 1.15
Dissecting the substrate recognition of 3-O-sulfotransferase for the biosynthesis of anticoagulant heparin. Proc Natl Acad Sci U S A (2012) 1.11
Evolution of glycosaminoglycans: Comparative biochemical study. Commun Integr Biol (2011) 1.02
Elucidating glycosaminoglycan-protein-protein interactions using carbohydrate microarray and computational approaches. Proc Natl Acad Sci U S A (2011) 1.00
Role of arginine 132 and lysine 133 in heparin binding to and activation of antithrombin. J Biol Chem (1996) 0.99
Role of arginine 129 in heparin binding and activation of antithrombin. J Biol Chem (2000) 0.97
Identification of basic amino acid residues in thrombin essential for heparin-catalyzed inactivation by antithrombin III. J Biol Chem (1994) 0.96
Lysine 114 of antithrombin is of crucial importance for the affinity and kinetics of heparin pentasaccharide binding. J Biol Chem (2001) 0.96
Influence of Arginines 93, 97, and 101 of thrombin to its functional specificity. Biochemistry (1997) 0.94
Molecular mechanism of substrate specificity for heparan sulfate 2-O-sulfotransferase. J Biol Chem (2014) 0.94
Understanding Dermatan Sulfate-Heparin Cofactor II Interaction through Virtual Library Screening. ACS Med Chem Lett (2010) 0.93
Thermodynamics of charged oligopeptide-heparin interactions. Biochemistry (1995) 0.93
Binding of bovine serum albumin to heparin determined by turbidimetric titration and frontal analysis continuous capillary electrophoresis. Anal Biochem (2001) 0.92
Computational approaches to the identification of heparin-binding sites on the surfaces of proteins. Biochem Soc Trans (2006) 0.91
Platelet endothelial cell adhesion molecule 1 (PECAM-1) and its interactions with glycosaminoglycans: 1. Molecular modeling studies. Biochemistry (2008) 0.89
Specificity of the basic side chains of Lys114, Lys125, and Arg129 of antithrombin in heparin binding. Biochemistry (2002) 0.89
Requirement of lysine residues outside of the proposed pentasaccharide binding region for high affinity heparin binding and activation of human antithrombin III. J Biol Chem (1996) 0.89
On the specificity of heparin/heparan sulfate binding to proteins. Anion-binding sites on antithrombin and thrombin are fundamentally different. PLoS One (2012) 0.88
The "CPC clip motif": a conserved structural signature for heparin-binding proteins. PLoS One (2012) 0.86
Molecular modeling of the interaction between heparan sulfate and cellular growth factors: bringing pieces together. Glycobiology (2011) 0.86
Toward a robust computational screening strategy for identifying glycosaminoglycan sequences that display high specificity for target proteins. Glycobiology (2014) 0.85
Prediction of heparin binding sites in bone morphogenetic proteins (BMPs). Biochim Biophys Acta (2012) 0.85
Free energy calculations of glycosaminoglycan-protein interactions. Glycobiology (2009) 0.84
Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. J Biol Chem (1994) 0.83
Chemoenzymatically prepared heparan sulfate containing rare 2-O-sulfonated glucuronic acid residues. ACS Chem Biol (2015) 0.83
AutoMap: a tool for analyzing protein-ligand recognition using multiple ligand binding modes. J Mol Graph Model (2013) 0.81
Docking server for the identification of heparin binding sites on proteins. J Chem Inf Model (2014) 0.81
Development and application of site mapping methods for the design of glycosaminoglycans. Glycobiology (2014) 0.80
Flexibility and explicit solvent in molecular-dynamics-based docking of protein-glycosaminoglycan systems. J Chem Inf Model (2014) 0.79
Importance of the polarity of the glycosaminoglycan chain on the interaction with FGF-1. Glycobiology (2014) 0.78
Langerin-heparin interaction: two binding sites for small and large ligands as revealed by a combination of NMR spectroscopy and cross-linking mapping experiments. J Am Chem Soc (2015) 0.78
Coarse-grained model of glycosaminoglycans. J Chem Inf Model (2014) 0.76